Pharmafile Logo

2013 trends

- PMLiVE

Cutting through the noise: CRISPR

AstraZeneca looks to lead an R&D revolution as the company invests in CRISPR and functional genomics drug discovery

Going digital

Medical devices, Medicine 2.0 and beyond

Lighthouse Medical Communications US appoints Lisa Druce as its new Managing Partner

Lighthouse Medical Communications US, a Lucid Group company, is delighted to announce the appointment of its new Managing Partner, Lisa Druce.Lisa is an experienced strategic business leader and healthcare communications...

Lucid Group Communications Limited

- PMLiVE

Merck puts prostate cancer firmly in Keytruda’s sights

Lynparza combination could open up huge new market

International Childhood Cancer Day Infographic

International Childhood Cancer Day 2019

The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...

Cuttsy + Cuttsy

- PMLiVE

AZ says dropping MedImmune will help ‘streamline’ its R&D

Will also drop other candidates that haven’t hit the mark

- PMLiVE

GW Pharma’s cannabis-based medicine to be tested in dementia

Trial will be funded by Alzheimer’s Research UK

- PMLiVE

Biosimilar Herceptin helps Roche gain new Perjeta recommendation

NICE decision puts NHS in vanguard for new use

- PMLiVE

Immuno-oncology in 2019: the rapid evolution continues

Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?

- PMLiVE

FCB Health’s Neon attracts new managing director

Mardene Miller will lead the agency with co-managing director Kevin McHale

- PMLiVE

Lucid Group acquires digital and creative agency Bluedog

The move comes as the group celebrates its 12-year anniversary

- PMLiVE

Novartis’ Egatan gains US approval for neglected tropical disease

US approval removes barrier to greater access

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links